Volume 132, Issue 1 pp. 226-234
RESEARCH ARTICLE

Development of Machine Learning Models to Predict Tumor Endoprosthesis Survival

Barlas Goker

Corresponding Author

Barlas Goker

Department of Orthopedic Surgery, Montefiore Medical Center, Bronx, New York, USA

Correspondence: Barlas Goker ([email protected])

Search for more papers by this author
Andrew Brook

Andrew Brook

Albert Einstein College of Medicine, Bronx, New York, USA

Search for more papers by this author
Ranxin Zhang

Ranxin Zhang

Department of Orthopedic Surgery, Montefiore Medical Center, Bronx, New York, USA

Search for more papers by this author
Boudewijn Aasman

Boudewijn Aasman

Montefiore Medical Center and Albert Einstein College of Medicine, Center for Health Data Innovations, Bronx, New York, USA

Search for more papers by this author
Jichuan Wang

Jichuan Wang

Department of Orthopedic Surgery, Montefiore Medical Center, Bronx, New York, USA

Musculoskeletal Tumor Center, Beijing Key Laboratory for Musculoskeletal Tumors, Peking University People's Hospital, Beijing, China

Search for more papers by this author
Alexander Ferrena

Alexander Ferrena

Albert Einstein College of Medicine, Institute for Clinical and Translational Research, Bronx, New York, USA

Search for more papers by this author
Parsa Mirhaji

Parsa Mirhaji

Montefiore Medical Center and Albert Einstein College of Medicine, Center for Health Data Innovations, Bronx, New York, USA

Search for more papers by this author
Rui Yang

Rui Yang

Department of Orthopedic Surgery, Montefiore Medical Center, Bronx, New York, USA

Albert Einstein College of Medicine, Bronx, New York, USA

Search for more papers by this author
Bang H. Hoang

Bang H. Hoang

Department of Orthopedic Surgery, Montefiore Medical Center, Bronx, New York, USA

Albert Einstein College of Medicine, Bronx, New York, USA

Search for more papers by this author
David S. Geller

David S. Geller

Department of Orthopedic Surgery, Montefiore Medical Center, Bronx, New York, USA

Albert Einstein College of Medicine, Bronx, New York, USA

Search for more papers by this author
First published: 12 June 2025

The present study was performed at Montefiore Medical Center.

ABSTRACT

Background and Objectives

Endoprosthetic reconstruction is the preferred approach for limb salvage surgery for many patients following malignant bone tumor resection. Implant failure is a common complication, however, there are no reliable means with which to offer patient-specific survival estimations. Implant survival predictions can set patient expectations and may guide treatment planning. This study aims to test and compare machine-learning models for the prediction of early tumor endoprosthetic implant survival.

Methods

A single-center retrospective series of 138 cases (mean age 41, 70 males, 68 females) was split into an 80:20 training and testing set. XGBoost, random forest, decision tree learning, and logistic regression were trained and assessed for model performance. After an initial review, age, sex, body mass index, diagnosis, location, resection length, and number of surgeries were selected as features. The output variables were 12-month, 24-month, and 36-month implant survival.

Results

Random forest had the best performance at 12, 24, and 36 months with an area under the curve (AUC) of 0.96, 0.89, 0.88; accuracy of 0.92, 0.83, 0.75; and Brier score of 0.09, 0.11, 0.20, respectively. Overall, the models performed better at 12 months compared to the other time points. The most important feature at 12 months was resection length (0.17), whereas age was most important at 24 months (0.15) and 36 months (0.17). Online tools were created based on the random forest models.

Conclusions

Machine learning models can be leveraged for the accurate prediction of early tumor endoprosthetic survival. These represent the first ML models used to predict endoprosthetic implant survival beyond 1 year and the first to include upper extremity implants. This offers better patient-specific prognostication which can help manage patient expectations and may guide recommendations.

Level of Evidence:

Level III.

Conflicts of Interest

The authors declare no conflicts of interest.

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.